| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | PH_dom-like | SPTBN4 SPTBN5 RANBP2 PTPN13 PLEKHG7 OSBPL3 FARP1 FRMD7 OSBPL11 TNS2 LRBA RASAL2 | 4.97e-07 | 426 | 85 | 12 | IPR011993 |
| Domain | - | SPTBN4 SPTBN5 RANBP2 PTPN13 PLEKHG7 OSBPL3 FARP1 FRMD7 OSBPL11 TNS2 RASAL2 | 1.57e-06 | 391 | 85 | 11 | 2.30.29.30 |
| Domain | - | 2.05e-05 | 333 | 85 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.15e-05 | 335 | 85 | 9 | IPR015943 | |
| Domain | WD40 | 2.35e-05 | 259 | 85 | 8 | PF00400 | |
| Domain | WD40 | 3.00e-05 | 268 | 85 | 8 | SM00320 | |
| Domain | WD40_repeat | 3.33e-05 | 272 | 85 | 8 | IPR001680 | |
| Domain | WD_REPEATS_1 | 3.89e-05 | 278 | 85 | 8 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.99e-05 | 279 | 85 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.99e-05 | 279 | 85 | 8 | PS50294 | |
| Domain | WD40_repeat_dom | 6.20e-05 | 297 | 85 | 8 | IPR017986 | |
| Domain | WD40_repeat_CS | 1.03e-04 | 164 | 85 | 6 | IPR019775 | |
| Domain | KIND_dom | 2.03e-04 | 5 | 85 | 2 | IPR011019 | |
| Domain | KIND | 2.03e-04 | 5 | 85 | 2 | SM00750 | |
| Domain | KIND | 2.03e-04 | 5 | 85 | 2 | PS51377 | |
| Domain | FERM_C | 2.19e-04 | 26 | 85 | 3 | PF09380 | |
| Domain | FERM_C | 2.46e-04 | 27 | 85 | 3 | SM01196 | |
| Domain | FERM_PH-like_C | 2.46e-04 | 27 | 85 | 3 | IPR018980 | |
| Domain | PH | 2.75e-04 | 278 | 85 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 2.81e-04 | 279 | 85 | 7 | PS50003 | |
| Domain | PH_domain | 2.88e-04 | 280 | 85 | 7 | IPR001849 | |
| Domain | FERM_N | 4.50e-04 | 33 | 85 | 3 | PF09379 | |
| Domain | FERM_N | 4.50e-04 | 33 | 85 | 3 | IPR018979 | |
| Domain | PH_dom-spectrin-type | 7.22e-04 | 9 | 85 | 2 | IPR001605 | |
| Domain | ARM-type_fold | 8.96e-04 | 339 | 85 | 7 | IPR016024 | |
| Domain | FERM_M | 1.20e-03 | 46 | 85 | 3 | PF00373 | |
| Domain | Oxysterol-bd | 1.31e-03 | 12 | 85 | 2 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 1.31e-03 | 12 | 85 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 1.31e-03 | 12 | 85 | 2 | PF01237 | |
| Domain | OSBP | 1.31e-03 | 12 | 85 | 2 | PS01013 | |
| Domain | - | 1.44e-03 | 49 | 85 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 1.44e-03 | 49 | 85 | 3 | IPR019748 | |
| Domain | FERM_domain | 1.44e-03 | 49 | 85 | 3 | IPR000299 | |
| Domain | FERM_1 | 1.53e-03 | 50 | 85 | 3 | PS00660 | |
| Domain | FERM_2 | 1.53e-03 | 50 | 85 | 3 | PS00661 | |
| Domain | FERM_3 | 1.53e-03 | 50 | 85 | 3 | PS50057 | |
| Domain | KAZAL_2 | 1.53e-03 | 50 | 85 | 3 | PS51465 | |
| Domain | Band_41_domain | 1.53e-03 | 50 | 85 | 3 | IPR019749 | |
| Domain | B41 | 1.53e-03 | 50 | 85 | 3 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.53e-03 | 50 | 85 | 3 | IPR014352 | |
| Domain | FERM-adjacent | 1.55e-03 | 13 | 85 | 2 | IPR014847 | |
| Domain | FA | 1.55e-03 | 13 | 85 | 2 | SM01195 | |
| Domain | FA | 1.55e-03 | 13 | 85 | 2 | PF08736 | |
| Domain | Kazal_dom | 1.62e-03 | 51 | 85 | 3 | IPR002350 | |
| Domain | TSP_1 | 2.97e-03 | 63 | 85 | 3 | PF00090 | |
| Domain | Cation_ATPase_N | 2.99e-03 | 18 | 85 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 2.99e-03 | 18 | 85 | 2 | SM00831 | |
| Domain | TSP1 | 3.24e-03 | 65 | 85 | 3 | SM00209 | |
| Domain | TSP1_rpt | 3.24e-03 | 65 | 85 | 3 | IPR000884 | |
| Domain | TSP1 | 3.24e-03 | 65 | 85 | 3 | PS50092 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.33e-03 | 19 | 85 | 2 | IPR004014 | |
| Domain | - | 3.44e-03 | 222 | 85 | 5 | 1.25.10.10 | |
| Domain | PH | 3.93e-03 | 229 | 85 | 5 | PF00169 | |
| Domain | CH | 4.00e-03 | 70 | 85 | 3 | PF00307 | |
| Domain | Ez/rad/moesin-like | 4.06e-03 | 21 | 85 | 2 | IPR000798 | |
| Domain | - | 4.16e-03 | 71 | 85 | 3 | 1.10.418.10 | |
| Domain | CH | 4.50e-03 | 73 | 85 | 3 | PS50021 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RANBP2 TRMT10C HSPA4L BZW2 OSBPL3 FANCI IFT172 DTL SMU1 LRP1 GEMIN4 TNS2 PRKDC | 1.04e-06 | 974 | 88 | 13 | 28675297 |
| Pubmed | 1.19e-06 | 418 | 88 | 9 | 34709266 | ||
| Pubmed | 1.83e-06 | 326 | 88 | 8 | 17015433 | ||
| Pubmed | RANBP2 DCAF13 CHERP FANCI SMU1 GEMIN4 KIF14 PRKDC TRIP12 NXF1 | 6.16e-06 | 653 | 88 | 10 | 22586326 | |
| Pubmed | 1.04e-05 | 17 | 88 | 3 | 10668806 | ||
| Pubmed | 1.83e-05 | 322 | 88 | 7 | 26514267 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 24423473 | ||
| Pubmed | 3.50e-05 | 638 | 88 | 9 | 33239621 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 14729961 | ||
| Pubmed | Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice. | 3.79e-05 | 4 | 88 | 2 | 1531270 | |
| Pubmed | Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. | 3.79e-05 | 4 | 88 | 2 | 19851285 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 12023295 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 3.94e-05 | 498 | 88 | 8 | 36634849 | |
| Pubmed | 4.40e-05 | 251 | 88 | 6 | 27507650 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | SUPT3H TRMT10C USP17L2 RAE1 FANCI DTL SMU1 LRP1 OSBPL11 BTBD9 TRIP12 | 4.67e-05 | 1005 | 88 | 11 | 19615732 |
| Pubmed | 5.70e-05 | 263 | 88 | 6 | 34702444 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 TRMT10C DCAF13 CHERP HSPA4L FANCI SMU1 GEMIN4 KIF14 PRKDC TTC3 NXF1 RASAL2 | 5.97e-05 | 1425 | 88 | 13 | 30948266 |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 23028956 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 27197203 | ||
| Pubmed | Mutations in tap uncouple RNA export activity from translocation through the nuclear pore complex. | 6.30e-05 | 5 | 88 | 2 | 16314397 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 17932312 | ||
| Pubmed | 7.79e-05 | 708 | 88 | 9 | 39231216 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANBP2 TRMT10C PTPN13 CHERP RAE1 FARP1 SMU1 SPOCK2 PRKDC TRIP12 NXF1 | 9.02e-05 | 1082 | 88 | 11 | 38697112 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RANBP2 IGHA1 HSPA4L BZW2 OSBPL3 FANCI GEMIN4 SPIRE1 SNRK LRBA PKD1L3 RASAL2 | 9.40e-05 | 1284 | 88 | 12 | 17353931 |
| Pubmed | Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells. | 9.43e-05 | 6 | 88 | 2 | 28827518 | |
| Pubmed | HARS2 RANBP2 SUPT3H TRMT10C PTPN13 RAP2B FARP1 SMU1 GEMIN4 KIF14 SPIRE1 TAF1L NXF1 | 9.81e-05 | 1497 | 88 | 13 | 31527615 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.18e-04 | 583 | 88 | 8 | 29844126 | |
| Pubmed | 1.32e-04 | 7 | 88 | 2 | 25583577 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.36e-04 | 942 | 88 | 10 | 31073040 | |
| Pubmed | 1.45e-04 | 40 | 88 | 3 | 37516964 | ||
| Pubmed | 1.48e-04 | 197 | 88 | 5 | 31620119 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 1.55e-04 | 607 | 88 | 8 | 39147351 | |
| Pubmed | 1.64e-04 | 457 | 88 | 7 | 22190034 | ||
| Pubmed | 1.74e-04 | 204 | 88 | 5 | 25659154 | ||
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 1.75e-04 | 8 | 88 | 2 | 31375530 | |
| Pubmed | 2.09e-04 | 634 | 88 | 8 | 34591612 | ||
| Pubmed | 2.18e-04 | 214 | 88 | 5 | 22199357 | ||
| Pubmed | 2.34e-04 | 47 | 88 | 3 | 11208732 | ||
| Pubmed | 2.73e-04 | 660 | 88 | 8 | 32780723 | ||
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 17478428 | ||
| Pubmed | 2.97e-04 | 847 | 88 | 9 | 35850772 | ||
| Pubmed | 3.27e-04 | 363 | 88 | 6 | 25036637 | ||
| Pubmed | 3.41e-04 | 130 | 88 | 4 | 12421765 | ||
| Pubmed | 3.43e-04 | 11 | 88 | 2 | 11483621 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SPTBN5 HARS2 TRMT10C ALMS1 HSPA4L OSBPL3 DTL GEMIN4 OSBPL11 SPIRE1 ZDBF2 TTC3 | 3.83e-04 | 1496 | 88 | 12 | 32877691 |
| Pubmed | SPTBN4 PTPN13 IFT172 DENND6B LRP1 SPOCK2 PRKDC LRBA TTC3 TRIP12 RASAL2 | 3.97e-04 | 1285 | 88 | 11 | 35914814 | |
| Pubmed | A family of 12 human genes containing oxysterol-binding domains. | 4.11e-04 | 12 | 88 | 2 | 11735225 | |
| Pubmed | An oxysterol-binding protein family identified in the mouse. | 4.11e-04 | 12 | 88 | 2 | 12215260 | |
| Pubmed | PTPN13 OSBPL3 FARP1 DTL OSBPL11 SPIRE1 SPOCK2 TTC3 TRIP12 AKR1C2 | 4.15e-04 | 1084 | 88 | 10 | 11544199 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 4.20e-04 | 704 | 88 | 8 | 29955894 | |
| Pubmed | 4.44e-04 | 250 | 88 | 5 | 33536335 | ||
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 11682476 | ||
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 18796539 | ||
| Pubmed | 4.95e-04 | 549 | 88 | 7 | 38280479 | ||
| Pubmed | HARS2 TRMT10C RAE1 OSBPL3 FARP1 SMU1 GEMIN4 TRIP12 AKR1C2 DIRAS2 NXF1 | 6.81e-04 | 1371 | 88 | 11 | 36244648 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.98e-04 | 954 | 88 | 9 | 36373674 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 6.99e-04 | 582 | 88 | 7 | 20467437 | |
| Pubmed | JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase. | 7.42e-04 | 16 | 88 | 2 | 26291670 | |
| Pubmed | 7.46e-04 | 963 | 88 | 9 | 28671696 | ||
| Pubmed | Human colostrum: identification of minor proteins in the aqueous phase by proteomics. | 7.80e-04 | 162 | 88 | 4 | 16502470 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 8.15e-04 | 432 | 88 | 6 | 23455922 | |
| Pubmed | 9.27e-04 | 75 | 88 | 3 | 20637190 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 9.43e-04 | 18 | 88 | 2 | 12119179 | |
| Pubmed | 9.61e-04 | 446 | 88 | 6 | 24255178 | ||
| Pubmed | SPTBN4 RANBP2 DCAF13 NLRP7 HSPA4L DTL CAPRIN2 PRKDC TTC3 TRIP12 FBXO15 | 1.03e-03 | 1442 | 88 | 11 | 35575683 | |
| Pubmed | Protein interaction discovery using parallel analysis of translated ORFs (PLATO). | 1.04e-03 | 78 | 88 | 3 | 23503679 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 1.04e-03 | 302 | 88 | 5 | 30561431 | |
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 1.05e-03 | 19 | 88 | 2 | 17599069 | |
| Pubmed | 1.08e-03 | 814 | 88 | 8 | 23251661 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.15e-03 | 180 | 88 | 4 | 30110629 | |
| Pubmed | 1.17e-03 | 20 | 88 | 2 | 21689717 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | AP4E1 SUPT3H OSBPL3 FANCI FRMD7 DNAH17 WNT16 CAPRIN2 SLC30A8 RASAL2 | 1.18e-03 | 1242 | 88 | 10 | 30973865 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.22e-03 | 313 | 88 | 5 | 38270169 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.25e-03 | 184 | 88 | 4 | 32908313 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HARS2 TRMT10C DCAF13 SMU1 GEMIN4 KIF14 PRKDC TRIP12 NXF1 RASAL2 | 1.29e-03 | 1257 | 88 | 10 | 36526897 |
| Pubmed | 1.29e-03 | 21 | 88 | 2 | 30111536 | ||
| Pubmed | 1.29e-03 | 21 | 88 | 2 | 24923560 | ||
| Pubmed | 1.41e-03 | 22 | 88 | 2 | 31839203 | ||
| Pubmed | 1.52e-03 | 89 | 88 | 3 | 36861887 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.54e-03 | 861 | 88 | 8 | 36931259 | |
| Pubmed | 1.58e-03 | 332 | 88 | 5 | 25693804 | ||
| Pubmed | 1.58e-03 | 332 | 88 | 5 | 37433992 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RANBP2 SUPT3H CHERP RAE1 OSBPL3 SMU1 PRKDC TRIP12 TAF1L NXF1 | 1.60e-03 | 1294 | 88 | 10 | 30804502 |
| Pubmed | 1.80e-03 | 686 | 88 | 7 | 29987050 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RANBP2 TRMT10C DCAF13 CHERP RAE1 HSPA4L PRKDC LRBA TRIP12 NXF1 | 1.83e-03 | 1318 | 88 | 10 | 30463901 |
| Pubmed | 1.83e-03 | 25 | 88 | 2 | 10601273 | ||
| Pubmed | Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. | 1.83e-03 | 25 | 88 | 2 | 15385968 | |
| Pubmed | PIDD orchestrates translesion DNA synthesis in response to UV irradiation. | 1.83e-03 | 25 | 88 | 2 | 21415862 | |
| Pubmed | VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase. | 1.83e-03 | 25 | 88 | 2 | 24885147 | |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.83e-03 | 25 | 88 | 2 | 8493579 | |
| Pubmed | 1.98e-03 | 26 | 88 | 2 | 12228227 | ||
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 1.98e-03 | 26 | 88 | 2 | 23892084 | |
| Pubmed | 1.99e-03 | 209 | 88 | 4 | 36779422 | ||
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 2.24e-03 | 102 | 88 | 3 | 15778465 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.27e-03 | 361 | 88 | 5 | 26167880 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 2.28e-03 | 217 | 88 | 4 | 31685992 | |
| Pubmed | 2.29e-03 | 28 | 88 | 2 | 17041588 | ||
| Pubmed | 2.29e-03 | 28 | 88 | 2 | 18839057 | ||
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 2.29e-03 | 28 | 88 | 2 | 35227662 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.37e-03 | 104 | 88 | 3 | 31240132 | |
| GeneFamily | WD repeat domain containing | 5.44e-06 | 262 | 67 | 8 | 362 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.14e-04 | 206 | 67 | 6 | 682 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.81e-04 | 7 | 67 | 2 | 1113 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 8.42e-04 | 50 | 67 | 3 | 1293 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 8.72e-04 | 12 | 67 | 2 | 670 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 8.92e-04 | 51 | 67 | 3 | 870 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 1.99e-03 | 18 | 67 | 2 | 498 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.03e-05 | 72 | 85 | 5 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | SUPT3H ALMS1 HSPA4L FANCI CAPRIN2 KIF14 PRKDC PHYHIPL FBXO15 | 2.36e-05 | 385 | 85 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 4.56e-05 | 419 | 85 | 9 | GSM476664_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.03e-05 | 110 | 85 | 5 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SUPT3H DCAF13 ALMS1 HSPA4L FANCI CAPRIN2 KIF14 PRKDC LRBA PHYHIPL FBXO15 RASAL2 | 1.00e-04 | 820 | 85 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.51e-09 | 194 | 87 | 8 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.42e-08 | 190 | 87 | 7 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-07 | 193 | 87 | 7 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-06 | 180 | 87 | 6 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-06 | 180 | 87 | 6 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-06 | 180 | 87 | 6 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.65e-06 | 184 | 87 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-06 | 185 | 87 | 6 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-06 | 190 | 87 | 6 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.25e-06 | 194 | 87 | 6 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-06 | 195 | 87 | 6 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-06 | 195 | 87 | 6 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Caecum-(1)_T_cell-(18)_cycling_gd_T|Caecum / shred on region, Cell_type, and subtype | 2.53e-06 | 198 | 87 | 6 | 64278d8831c81874937e76b561c53928dfc437c5 | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.53e-06 | 198 | 87 | 6 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | Caecum-T_cell-cycling_gd_T|Caecum / Region, Cell class and subclass | 2.53e-06 | 198 | 87 | 6 | 5b719b67f8384863077070e1eb7e04a320e6dab4 | |
| ToppCell | Caecum-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 2.60e-06 | 199 | 87 | 6 | 64d1e495307a91bc012130613126d86e0cf170b0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-06 | 130 | 87 | 5 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 155 | 87 | 5 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-05 | 157 | 87 | 5 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 169 | 87 | 5 | 8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d | |
| ToppCell | NS-critical-d_0-4-Epithelial-FOXN4+|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.21e-05 | 172 | 87 | 5 | a00bb44d33658cb3a98accd6b60f3ce964c425b4 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 2.27e-05 | 173 | 87 | 5 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 174 | 87 | 5 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | Healthy/Control-Plasmablast|Healthy/Control / Disease group and Cell class | 2.34e-05 | 174 | 87 | 5 | 97d19ef3240a1f648c6befaabb9ce45ad469cbce | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-05 | 176 | 87 | 5 | aab9603b7943b7f7243eb6190ebba998566196f3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-05 | 176 | 87 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.53e-05 | 177 | 87 | 5 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-05 | 177 | 87 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Healthy_donor-Plasmablast|Healthy_donor / disease group, cell group and cell class (v2) | 2.60e-05 | 178 | 87 | 5 | 388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde | |
| ToppCell | severe-multiplets|World / disease stage, cell group and cell class | 2.90e-05 | 182 | 87 | 5 | 5e30ec7120a988d9ee3000513e1209618f28f5f9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 182 | 87 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 182 | 87 | 5 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.97e-05 | 183 | 87 | 5 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.13e-05 | 185 | 87 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 3.13e-05 | 185 | 87 | 5 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-05 | 186 | 87 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-05 | 186 | 87 | 5 | 993c58ef4445bf81bbc9b489635883848b5b4c8e | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.21e-05 | 186 | 87 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 189 | 87 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 190 | 87 | 5 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 190 | 87 | 5 | 050d6e0546954675b6adbfecb67854b1e09739d1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.56e-05 | 190 | 87 | 5 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.56e-05 | 190 | 87 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 3.65e-05 | 191 | 87 | 5 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-05 | 193 | 87 | 5 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.83e-05 | 193 | 87 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.83e-05 | 193 | 87 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.83e-05 | 193 | 87 | 5 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-05 | 193 | 87 | 5 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 3.93e-05 | 194 | 87 | 5 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 194 | 87 | 5 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.93e-05 | 194 | 87 | 5 | ffba703f61faaac8b4b9a5e46cd335214303de7b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.93e-05 | 194 | 87 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-05 | 195 | 87 | 5 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-05 | 195 | 87 | 5 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.02e-05 | 195 | 87 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.02e-05 | 195 | 87 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | COVID-19_Convalescent-CD4+_Tcm|COVID-19_Convalescent / Disease condition and Cell class | 4.12e-05 | 196 | 87 | 5 | f2a5eeb1cebde2762865ab29792370b751214c4d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-05 | 196 | 87 | 5 | 9d4f0a95e49bda25864cbe27e4e86096cba5609f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 196 | 87 | 5 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 196 | 87 | 5 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-05 | 197 | 87 | 5 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.22e-05 | 197 | 87 | 5 | 196eaecef7003ed83f323c1f157c6a3594650097 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.22e-05 | 197 | 87 | 5 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.22e-05 | 197 | 87 | 5 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.22e-05 | 197 | 87 | 5 | 6fe013f98c64b3c5a4e61002254717fb411f8e59 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.33e-05 | 198 | 87 | 5 | 715ecad21f572b195ff3b78216b1a7b32bbb4ace | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-05 | 198 | 87 | 5 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasmablast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-05 | 198 | 87 | 5 | cfbe0bae21b6cd9cd15d3e659b618b44cfe3eaec | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.33e-05 | 198 | 87 | 5 | 9d03768f8b6c74e060c5f045508538f9b331f469 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.33e-05 | 198 | 87 | 5 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.33e-05 | 198 | 87 | 5 | 3811d9e3e54bbe8b208c591697e43b55ab5bbf0e | |
| ToppCell | MS-cycling-|MS / Condition, Cell_class and T cell subcluster | 4.33e-05 | 198 | 87 | 5 | 19c5d6b65de490118574b1f86b45c58b3a51df7f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-05 | 198 | 87 | 5 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.33e-05 | 198 | 87 | 5 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | MS-cycling|MS / Condition, Cell_class and T cell subcluster | 4.33e-05 | 198 | 87 | 5 | 0c22f2cc0e5ca91cabcd4aac2b9ef05af47e967f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.33e-05 | 198 | 87 | 5 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-05 | 199 | 87 | 5 | d7dbc551c05da32c698908348572fb0ce1166e10 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.43e-05 | 199 | 87 | 5 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 199 | 87 | 5 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-05 | 199 | 87 | 5 | 6a89c3a65fa50af92585c52bec203bcff6f94efc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.43e-05 | 199 | 87 | 5 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 199 | 87 | 5 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.43e-05 | 199 | 87 | 5 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-pDC|Bac-SEP / Disease, condition lineage and cell class | 4.43e-05 | 199 | 87 | 5 | 7f6569de050262f3d8d9d41c0f0cc139de85c0cb | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.43e-05 | 199 | 87 | 5 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.54e-05 | 200 | 87 | 5 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.54e-05 | 200 | 87 | 5 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Macroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-05 | 200 | 87 | 5 | 88d66550781a3c9102ff7455f5cff6fb072943cd | |
| ToppCell | Macroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-05 | 200 | 87 | 5 | d6a059b0ef763c281c60b1ac76da6079ea822f80 | |
| ToppCell | Macroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-05 | 200 | 87 | 5 | 16269fa4adb28fc6ed032bbdba8781237dd0d249 | |
| ToppCell | Macroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-05 | 200 | 87 | 5 | c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_T_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 4.54e-05 | 200 | 87 | 5 | c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.54e-05 | 200 | 87 | 5 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Macroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-05 | 200 | 87 | 5 | 79634b1086934412ae92f259ab43554ce545008f | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.54e-05 | 200 | 87 | 5 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 126 | 87 | 4 | 8ae631694bbba40f64e55e2be8162d7a40eeadc5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 133 | 87 | 4 | f303ab771482281d8793974f9f5279cee09431fe | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Nxph2_Sla|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.38e-04 | 134 | 87 | 4 | 6d97fa07f55ae20c17b9d5262e893957cccc6dba | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 142 | 87 | 4 | 58c2882cb0ede8cc5d84c85a650d28267268e748 | |
| Disease | large artery stroke | 3.40e-04 | 113 | 86 | 4 | EFO_0005524 | |
| Disease | Bardet-Biedl Syndrome | 6.41e-04 | 13 | 86 | 2 | C0752166 | |
| Disease | colonic neoplasm, overall survival | 7.47e-04 | 14 | 86 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | diffuse idiopathic skeletal hyperostosis | 8.60e-04 | 15 | 86 | 2 | EFO_0007236 | |
| Disease | lysophosphatidylcholine 20:5 measurement | 1.39e-03 | 19 | 86 | 2 | EFO_0010364 | |
| Disease | blood metabolite measurement | 1.39e-03 | 19 | 86 | 2 | EFO_0005664 | |
| Disease | colorectal cancer | 1.94e-03 | 604 | 86 | 7 | MONDO_0005575 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 1.99e-03 | 85 | 86 | 3 | EFO_0000708, EFO_0006953 | |
| Disease | BMI-adjusted fasting blood glucose measurement | 2.04e-03 | 23 | 86 | 2 | EFO_0008036 | |
| Disease | fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement | 2.41e-03 | 25 | 86 | 2 | EFO_0004465, EFO_0004466, EFO_0004469 | |
| Disease | chromatid-type aberration frequency | 2.61e-03 | 26 | 86 | 2 | EFO_0009862 | |
| Disease | pain | 2.62e-03 | 196 | 86 | 4 | EFO_0003843 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CALMFSLDWIKAKTE | 501 | O14727 | |
| FKAWMAEKDANSVTS | 191 | Q9Y6E2 | |
| WKIMALDAIAKTCTF | 31 | Q6P093 | |
| TAWKMEDCIVDSCKF | 556 | Q4VNC0 | |
| LVDQDKTMFICKSSW | 131 | P05156 | |
| KCKISEEMSNFLAWL | 321 | P30939 | |
| DLCSYMSWKTRKDTQ | 341 | Q8TCU4 | |
| TESQSFRKKCFKEWM | 81 | Q9NZJ0 | |
| AICEANIETWMKDKS | 516 | Q8NEG7 | |
| VKWTSDSKYIMCGSD | 331 | Q9NV06 | |
| CSKKYEMTSDTWLSQ | 356 | Q8N608 | |
| SSEQKWMAVKCSLKT | 486 | O75185 | |
| KDDCLLMVWSVTNKS | 936 | Q9UPM8 | |
| DGTTAASCKDMAKTW | 5236 | Q9HC84 | |
| ASCKDMAKTWLVPDS | 5241 | Q9HC84 | |
| VFTASCDKTAKMWDL | 101 | P78406 | |
| CDKTAKMWDLSSNQA | 106 | P78406 | |
| MFTKKEGQWDCSVCL | 1661 | P49792 | |
| EEWSCPFMETSAKNK | 136 | P61225 | |
| MLSWTSKICKENSRE | 1006 | Q9NVI1 | |
| TFWSLEKFESKLAAM | 1136 | Q15058 | |
| WADQVSEKMGTCSKA | 1801 | Q07954 | |
| SCSMKLTIKEIWFSF | 1996 | Q2LD37 | |
| FTMASRDACKAFWKT | 256 | Q6ZUT3 | |
| DKAWLLSMIQSKCSV | 131 | Q9UBU9 | |
| KCFSCNSASERDKWM | 136 | Q9UJF2 | |
| CQAEVWSMFTAILKK | 106 | P50851 | |
| SMLIASNETWKKVEC | 1636 | O60449 | |
| CKSSDWFIHTCMAAK | 111 | Q8TDV0 | |
| AEKCWMKAAELSIKF | 1311 | Q9UG01 | |
| SWVLTAAHCMDESKK | 246 | P04070 | |
| DFTEQSQCMKTKFWK | 516 | Q9HB29 | |
| FDTVFWKCDMQKLTV | 116 | Q86V35 | |
| DTCTKDAISAGKNWM | 166 | Q8IWX8 | |
| MNDTRETCWKFFIEK | 2906 | Q9UFH2 | |
| MASRDFCKSFWKICV | 296 | Q9Y4F1 | |
| WKTDIFDGCIKSCSM | 411 | Q8NCQ5 | |
| RTWKCAFMETSAKLN | 141 | Q96HU8 | |
| AAEDWKKGDTFSCMV | 301 | P01876 | |
| CVNSLEKFHFKSWMS | 26 | P09668 | |
| TKSWTTPMCEEQDSK | 526 | Q6IMN6 | |
| KFTLCWTEFVDMKVH | 396 | O75072 | |
| KVITQSTAVKAMDWC | 396 | Q86Y33 | |
| MVADRTKVSCKSWQS | 511 | Q96Q07 | |
| LKAALDVWCKNESSM | 701 | Q7Z3Z3 | |
| KKCSIVIEMSKFEAW | 1681 | Q6ZTR5 | |
| SCERWMSCKSEFLKK | 296 | B1AKI9 | |
| EKMCLWSTDAISKDV | 121 | Q7L3B6 | |
| LWLQSSEDMEKCSKD | 211 | Q9H4L5 | |
| KKIWASSMDLLCTAD | 296 | Q12923 | |
| TFHCSWKMPKSEVAS | 456 | Q9BXB4 | |
| ITCDSFKISWEMDSK | 61 | Q96FC7 | |
| TMCKSVTTDEWKKVF | 36 | P59025 | |
| WSACSSSTCDKGKRM | 451 | Q9HCB6 | |
| CSSIDKLDKMAWKDV | 236 | P49590 | |
| MAKWNRASSCKLSEL | 311 | Q86VW1 | |
| KLCADFKRTGMDSNW | 866 | Q8IZX4 | |
| FSNKCSERWKTMSAK | 41 | B2RPK0 | |
| NSSWLREKKAALSMC | 51 | P41222 | |
| ESFTSLQMSKKGCVW | 1451 | Q7Z443 | |
| TLAKKCMLDWTDCNL | 186 | Q8WX94 | |
| EKSTWKMCISSTGNA | 681 | Q9NRH2 | |
| FLSSVEKMERWLCSK | 2581 | Q9NRC6 | |
| KKCTSLEESLSMTQW | 511 | Q13591 | |
| FWNKFKSTDTSCQMA | 16 | Q9HBM1 | |
| TVDLCATWEAMEKCK | 141 | P52895 | |
| TFFKMVSMRDCKSWL | 181 | Q9BZM4 | |
| ADESKWLCSEFKESM | 406 | Q9NUW8 | |
| KWKLCSASAICFIFM | 71 | Q8IWU4 | |
| KASKFRDWLDCSSME | 196 | O75486 | |
| WNMKTTECSNTFKSL | 376 | Q2TAY7 | |
| KVEKCISDAMSWLNS | 736 | O95757 | |
| WSTMEVCVDCKKFIS | 696 | Q08AE8 | |
| ELDIMKFICKDFWTT | 61 | Q86SZ2 | |
| FGALIDKTCMKWSTN | 591 | Q9NPD5 | |
| TAFWEQKCSVSSEMK | 351 | Q9HCK1 | |
| EFHMNCWKKLKTTTF | 686 | P53804 | |
| SAKDALLLWCQMKTA | 181 | Q9H254 | |
| AVKTCWKTMSSFEKI | 231 | Q9UBV4 | |
| KECSPWMSDFKVEFL | 3681 | P78527 | |
| CFFSWSLKKMELEFS | 181 | Q6ZNB5 | |
| AVASTKMSCKCNSWE | 166 | Q9Y2H8 | |
| KKTWMAQITTAISCF | 656 | Q6ZR37 | |
| KQSKMAEFLDWSLCN | 221 | Q9BTW9 | |
| LLMKSARNSCWSKDA | 221 | P50591 | |
| LCGSKADTWDAKTLM | 1866 | Q14669 | |
| WKTTMKSSVQEECVS | 66 | Q7L0Y3 | |
| DKLCSICKAMETWLS | 206 | Q63HR2 | |
| WYKMDDAKVTACSIT | 346 | Q6R6M4 | |
| CKDSIGWMFSKLDTS | 246 | Q92563 | |
| TFMVSCLKETVWMKF | 601 | P57678 |